Retinal endovascular surgery for central retinal vein occlusion: Initial experience of four surgeons

Retina

Volumn 25, Issue 5, 2005, Pages 625-632

  Bynoe, Leon A ^a   Hutchins, Robert K ^b   Lazarus, Howard S ^c   Friedberg, Mark A ^d  

^a Retina Associates of Coral Springs ^*  (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c American Eye Institute   (United States)

^d Mid Atlantic Eye Center   (United States)

Author keywords

Central retinal vein occlusion (CRVO); Retinal endovascular surgery (REVS); Tissue plasminogen activator (t PA)

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CATARACT; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA SURGERY; RETINA VEIN OCCLUSION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CATHETERIZATION; CLINICAL COMPETENCE; FEMALE; FIBRINOLYTIC AGENTS; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MALE; MIDDLE AGED; OPHTHALMOLOGY; PROSPECTIVE STUDIES; RETINAL VEIN; RETINAL VEIN OCCLUSION; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITRECTOMY;

EID: 23044465626     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200507000-00014     Document Type: Article

References (19)

1. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: The Central Vein Occlusion Study Group M report. Ophthalmology 1995;102:1425-1433.
2. The Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: The Central Vein Occlusion Study Group N report. Ophthalmology 1995;102:1434-1444.
3. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981;79:371-422.
4. Reim M, Bertram B, Wolf S. Treatment of occlusions of the central vein of the retina by plasminogen activator (rt-PA). Klin Wochenschr 1988;66(suppl 12):143-149.
5. Kreutzer A, Brunner R, Schager JH, et al. Lysetherapie mit rt-PA bei patienten mit stamm-oder zentralveneocclusion der retina. Fortschr Ophthalmol 1988;85:511-513.
6. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc 1996;94:471-504.
7. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:427-434.
8. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219-223.
9. Allf BF, DeJuan E Jr. In vivo cannulation of retinal vessels. Graefes Arch Clin Exp Ophthalmol 1987;225:221-225.
10. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 1998;126:142-144.
11. Weiss JN. Retinal surgery for treatment of central retinal vein occlusion. Ophthalmic Surg Lasers 2000;31:162-165.
12. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-2257.
13. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995;273:625-632.
14. Clarkson JG, The Central Vein Occlusion Study Group. Central Vein Occlusion Study, photographic protocol and early natural history. Trans Am Ophthalmol Soc 1994;92:203-215.
15. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as a treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002;120:1217-1219.
16. Bynoe LA, Weiss JN. Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol 2003;135:382-384.
17. Weiss JN, Bynoe LA. Retinal endovascular surgery for central and hemispheric retinal vein occlusion. Contemp Ophthalmol 2003;2:1-8.
18. Lam HD, Blumenkranz MS. Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection, and photocoagulation. Am J Ophthalmol 2002;134:609-611.
19. Kelley NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991;109:654-659.